The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma
NCT00207805
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
202
Enrollment
OTHER_GOV
Sponsor class
Conditions
Multiple Myeloma
Interventions
PROCEDURE:
autologous PBSC transplant
Sponsor
Centre National de Greffe de Moelle Osseuse